Sébert, M., Renneville, A., Bally, C., Peterlin, P., Beyne-Rauzy, O., Legros, L., . . . Fenaux, P. (2019). A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure. Haematologica.
Citação norma ChicagoSébert, Marie, et al. "A Phase II Study of Guadecitabine in Higher-risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia After Azacitidine Failure." Haematologica 2019.
MLA CitationSébert, Marie, et al. "A Phase II Study of Guadecitabine in Higher-risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia After Azacitidine Failure." Haematologica 2019.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.